The bidirectional causal effects of brain morphology across the life course and risk of Alzheimers disease: A cross-cohort comparison and Mendelian randomization meta-analysis
Korologou-Linden, R.; Xu, B.; Coulthard, E.; Walton, E.; Wearn, A.; Hemani, G.; White, T. J. H.; Cecil, C. A. M.; Sharp, T.; Tiemeier, H.; Banaschewski, T.; Bokde, A.; Quinlan, E.; Desrivieres, S.; Flor, H.; Grigis, A.; Gowland, P.; Heinz, A.; Bruhl, R.; Martinot, J.-L.; Paillere Martinot, M.-L.; Artiges, E.; Nees, F.; Papadopoulos Orfanos, D.; Paus, T.; Poustka, L.; Sabina, M.; Frohner, J.; Robinson, L.; Smolka, M.; Walter, H.; Winterer, J.; Whelan, R.; Schumann, G.; Howe, L. D.; Ben-Shlomo, Y.; Davies, N. M.; Anderson, E. L.
Show abstract
Neuropathological changes associated with Alzheimers disease (AD) can occur decades before clinical symptoms. We investigated whether neurodevelopment and/or neurodegeneration affects the risk of AD, through reducing structural brain reserve and/or accelerating brain atrophy, respectively. We used bidirectional two-sample Mendelian randomization to estimate the effects of genetic liability to AD on global and regional cortical thickness, total intracranial volume, volume of subcortical structures and cerebral white matter in 36,842 participants aged eight to 81 years across five independent cohorts, and the effects of global and regional cortical thickness and subcortical volumes on AD risk in 94,337 participants. Our findings show that AD risk alleles have an age-dependent effect on a range of cortical and subcortical brain measures that starts in mid-life, in non-clinical populations. Evidence for such effects across childhood and young adulthood is weak. We also found little evidence to suggest brain morphology alters AD risk. Thus, genetic liability to AD is likely to alter mechanisms and/or rates of neurodegeneration, rather than reduce structural brain reserve.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease 97%
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types 96%
- Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease 96%
Similar papers in this journal
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 96%
- Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2 96%
- Genetic architecture of brain age and its casual relations with brain and mental disorders 95%
Similar papers in this journal
- Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease 94%
- Multi-organ and Multi-omics Biological Aging Clocks: Generation, Interpretation, and Application 92%
- Neuronal apoE4 induces early hyperexcitability in select populations of hippocampal neurons by altering Nell2 expression 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.